Similar companies
| Company | Youtube Subscribers | |
|---|---|---|
 |
Johnson & JohnsonJNJ |
73,600 0% |
 |
PfizerPFE |
15 0% |
 |
AstrazenecaAZN |
16,500 0% |
 |
AbbVieABBV |
6,530 0% |
 |
ModernaMRNA |
12,000 0% |
Month over Month
Subscribers on Youtube.
| Oct 2024 | 3,720 | |
| Sep 2024 | 3,680 | |
| Aug 2024 | 3,640 |
How many users are subscribing to Bristol-Myers Squibb on Youtube?
Bristol-Myers Squibb has 3,730 subscribers on Youtube.
Analyzing Youtube Subscribers, how is Bristol-Myers Squibb performing compared to its industry peers?
Bristol-Myers Squibb underperforms its industry peers when it comes to Youtube Subscribers, ranking in the 5th percentile.
How has Bristol-Myers Squibb's Youtube Subscribers changed in the last month?
Bristol-Myers Squibb has experienced a 0.5% increase in YouTube subscribers over the last month, indicating an uptrend in audience engagement and digital presence.
Can the changes in Bristol-Myers Squibb's YouTube subscriber base be linked to its overall brand influence and business success?
With a positive growth and a substantial total of 3,730 Youtube subscribers, Bristol-Myers Squibb's is enhancing its brand recognition and influence on YouTube. This indicates a positive trend in audience engagement, contributing to the company's market presence.
Why is it important to monitor how many users are subscribing to Bristol-Myers Squibb on Youtube?
A growing subscriber base signifies increasing audience engagement, brand strength, and a potential customer base, which is positive news for Bristol-Myers Squibb. On the other hand, a declining number of YouTube subscribers can negatively impact a company's stock performance, signaling waning interest, decreased audience engagement, or a loss of market share. Therefore, monitoring YouTube subscribers is crucial for comprehending a company's online audience, gauging interest levels, and assessing customer perception, all of which can potentially influence the company's future trajectory and stock performance.
Sign up and get more insights on Bristol-Myers Squibb and its Youtube subscribers.
